RECEF
Recce Pharmaceuticals Ltd
Set alert
0.22 USD 0.00 0.00%
0.60 Day range 0.60
0.22 52-week range 0.60
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.60
- Prev close
- 0.22
- Mkt cap
- 67.27M
- Vol
- 60
- Avg vol
- 0
- EPS
- -0.06
- P/E
- 0.00
More statistics
- Low
- 0.60
- High
- 0.60
News
- Recce Pharmaceuticals signs Arrotex deal for RECCE 327 in Australia and New Zealand
- Recce Pharmaceuticals advances Phase 3 diabetic foot infection trial to independent data review
- Snowflake shares surge after Q2 beat, raised guidance
- Polymarket valuation hits $21bn as Trump Jr's firm leads $1bn round
- Baidu misses Q2 revenue and earnings estimates as core business slips
- Bank of England holds rates but three dissenters vote for hike
- Recce Pharmaceuticals positioned for US$66.9 billion US biodefence strategy
- Recce Pharmaceuticals advances dual Phase 3 programs and MENA licensing strategy in strong June quarter
- Twilio faces higher bar heading into quarterly earnings, says Jefferies
- Halliburton tops Q2 earnings estimates as CEO warns of softer oilfield services market
Your note
Sign in to keep a note on RECEF — it syncs with the Stock Master app.